Athos Gianella-Borradori
Observed names: A Gianella-Borradori, A. Gianella-Borradori
Observed institutions: California Institute of Technology, Fox Chase Cancer Center, Cliniques Universitaires Saint-Luc, Children's Hospital Los Angeles, NewYork–Presbyterian Hospital, University of California, Los Angeles, The Lundquist Institute, Cornell University, University of Utah, University of Michigan, Columbia University Irving Medical Center, University Hospital of Bern, Cancer Research UK, Centre Hospitalier Universitaire Vaudois, The Netherlands Cancer Institute, Heartlands Hospital, Chugai Pharma (United States), Guthy-Jackson Charitable Foundation, Merck Serono S.A. (Switzerland), Michigan Medicine, USC Norris Comprehensive Cancer Center, Stanford Medicine, Pinnacle Oncology Hematology, Cyclacel Pharmaceuticals (United Kingdom), University Hospital Cologne, Harbor–UCLA Medical Center, Weill Cornell Medicine, Sandoz Group AG (Switzerland), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Winship Cancer Institute, Chugai Pharmaceutical Co., Ltd. (Japan), Merck Healthcare KGaA, Darmstadt (Germany), Institut de Recherches Internationales Servier (France), University College London, University of Birmingham, Merck Serono S.p.A. (Italy), Stanford University, University of Lausanne
OpenAlex ID: A5063374954
